Liraglutide, which has been approved for reducing the risk of T2MD, has also been found to reduce the risk of major cardiovascular events in adults with established CVDs ( Table 1 Classification of GLP-1RAs
Additionally, it extends the C-terminal with a sequence of exenatide, and thirdly, it has an attached fatty acid side chain, similar to semaglutide, to prolong its half-life [16]
Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D et al
But this remains theoretical until clinical data emerges
In obesity, the proportion of type I muscle fibers decreases while that of type IIx muscle fibers increases
If the movement pattern, training load, weakness, mobility limitation, or stability issue that contributed to the injury is not corrected, symptoms may return